Produkty 83014-68-0

CAS 83014-68-0 występuje w naszej ofercie pod nazwami: Alphaxalone-d5 (major), >95% (HPLC), Alphaxalone-d5 (major). Oferty producentów: TRC, Biosynth. Dostępne opakowania: 10mg, 1mg, 5mg, 25mg, 50mg.

Alphaxalone-d5 (major), >95% (HPLC)
TRC
  • opakowanie: 10mg, 1mg
  • Warianty: 2
Zobacz produkt
Alphaxalone-d5 (major)
Biosynth
  • opakowanie: 10mg, 5mg, 25mg, 50mg
  • Warianty: 4
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-2,2,3,4,4-pentadeuterio-3-hydroxy-10,13-dimethyl-5,6,7,8,9,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-11-one (CAS 83014-68-0) to związek chemiczny o wzorze sumarycznym C21H32O3 i masie molowej 337.5 g/mol. Nazwa systematyczna IUPAC: (3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-2,2,3,4,4-pentadeuterio-3-hydroxy-10,13-dimethyl-5,6,7,8,9,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-11-one. InChIKey: DUHUCHOQIDJXAT-FXLSFZBWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H32O3
Masa molowa337.5 g/mol
Nazwa IUPAC(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-2,2,3,4,4-pentadeuterio-3-hydroxy-10,13-dimethyl-5,6,7,8,9,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-11-one
InChIKeyDUHUCHOQIDJXAT-FXLSFZBWSA-N
SMILES[2H][C@]1(C(C[C@]2([C@H](C1([2H])[2H])CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@H]4C(=O)C)C)C)([2H])[2H])O

Dane obliczone przez PubChem (NCBI)

Synonimy: Alphaxalone-d5, Alphaxalone-d5 (major), Alphaxalone D5
Powiązane formy tego związku
(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H32O3
Izomery (ten sam wzór sumaryczny)
methyl (1R,4S,5R,9S,10R,13S)-13-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate C21H32O3
(4-propoxyphenyl) 4-pentylcyclohexane-1-carboxylate C21H32O3
(4-pentoxyphenyl) 4-propylcyclohexane-1-carboxylate C21H32O3
methyl 4-[(2S,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoate C21H32O3
methyl 4-[3-[(2Z,5Z,8Z,11Z)-tetradeca-2,5,8,11-tetraenyl]oxiran-2-yl]butanoate C21H32O3
(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H32O3
(1R,2R,3aS,9aS)-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalene-2,5-diol C21H32O3
[(3S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C21H32O3
(7R,8R,9S,13S,14S)-3,3-dimethoxy-7,13-dimethyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C21H32O3
1-[(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H32O3
(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H32O3